IteraMed | IteraMed

Presentation at Drug Discovery Re-Invented Conference entitled: THE ARCHITECTURE AND SCIENCE OF VIRTUAL DRUG DISCOVERY IN THE CANNABINOID SPACE

by IteraMed | Aug 12, 2015 | IteraMed News

Ascot, UK, Dr. Kinney will describe for the first time a new family of molecules with improvements over Cannabidiol (“CBD”), a non-psychoactive neuroprotective agent from C. sativa. IteraMed Consulting has functioned as Kannalife Sciences’ medicinal and...

KannaLife Sciences, Inc. Signs Research and Development Agreements With Advanced Neural Dynamics and IteraMed in the Discovery of Novel Neuroprotectants

by IteraMed | Apr 4, 2013 | IteraMed News

KannaLife Sciences, Inc. (“KannaLife”) announces its collaboration with two experienced drug discovery organizations: Advanced Neural Dynamics and IteraMed. KannaLife will fund a new drug discovery project related to a laboratory validated phytochemical. The founding...

Presentation at Drug Discovery Re-Invented Conference entitled: THE ARCHITECTURE AND SCIENCE OF VIRTUAL DRUG DISCOVERY IN THE CANNABINOID SPACE﻿

KannaLife Sciences, Inc. Signs Research and Development Agreements With Advanced Neural Dynamics and IteraMed in the Discovery of Novel Neuroprotectants

Recent Posts

Presentation at Drug Discovery Re-Invented Conference entitled: THE ARCHITECTURE AND SCIENCE OF VIRTUAL DRUG DISCOVERY IN THE CANNABINOID SPACE